Nanobiotix (NASDAQ: NBTX)
FY 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.540 | ||||||
REV | 3.028M |
H1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | ||||||
REV | 1.589M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Nanobiotix (NASDAQ: NBTX) through any online brokerage.
Other companies in Nanobiotix’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), Inozyme Pharma (NASDAQ:INZY), Cogent Biosciences (NASDAQ:COGT), MoonLake (NASDAQ:MLTX) and Altimmune (NASDAQ:ALT).
The latest price target for Nanobiotix (NASDAQ: NBTX) was reported by Evercore ISI Group on Wednesday, January 6, 2021. The analyst firm set a price target for 0.00 expecting NBTX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Nanobiotix (NASDAQ: NBTX) is $5.42 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Nanobiotix.
Nanobiotix’s FY earnings are confirmed for Wednesday, March 30, 2022.
There is no upcoming split for Nanobiotix.
Nanobiotix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.